REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 185 filers reported holding REGENXBIO INC in Q2 2019. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $494 | -99.9% | 21,873 | +22.9% | 0.00% | 0.0% |
| Q2 2022 | $440,000 | -12.5% | 17,804 | +82.1% | 0.00% | 0.0% |
| Q2 2019 | $503,000 | -91.9% | 9,778 | -91.0% | 0.00% | -92.6% |
| Q1 2019 | $6,226,000 | +629.9% | 108,623 | +434.5% | 0.03% | +575.0% |
| Q4 2018 | $853,000 | -75.6% | 20,323 | -56.2% | 0.00% | -71.4% |
| Q3 2018 | $3,503,000 | -31.1% | 46,407 | -34.5% | 0.01% | -36.4% |
| Q2 2018 | $5,083,000 | +1768.8% | 70,866 | +402.3% | 0.02% | +2100.0% |
| Q1 2017 | $272,000 | – | 14,107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |